474-475 / 1708
My objectives are to:
•
To consider mechanisms of brain injury and their impact on patient
quality of life as a basis for designing strategies to reduce brain injury.
•
To consider new drug developments and the associated challenges of
delivering precision medicine to clinical practice.
•
To add the priority of delivery systems designed to optmize delivery of
drugs to CNS tumours as a priority for future clinical practice.